Stocktoria
ACCURAY INC ARAY
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-02-08
ACCURAY INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $458.5M | $446.6M | $447.6M | $429.9M | $396.3M |
| Gross profit | $147.0M | $142.9M | $154.0M | $160.0M | $159.5M |
| R&D expense | $47.9M | $49.7M | $57.1M | $57.8M | $52.7M |
| Operating income | $7.8M | $504,000 | $2.4M | $8.1M | $22.2M |
| Interest expense | $13.0M | $11.6M | $10.6M | $8.1M | $16.9M |
| Income tax | $2.7M | $3.7M | $2.5M | $3.3M | $1.8M |
| Net income | -$1.6M | -$15.5M | -$9.3M | -$5.3M | -$6.3M |
| EPS (diluted) | $-0.02 | $-0.16 | $-0.10 | $-0.06 | $-0.07 |
| Operating cash flow | $2.9M | -$11.9M | $15.5M | -$2.4M | $38.5M |
| Free cash flow | -$1.4M | -$15.5M | $2.9M | -$7.1M | $36.2M |
| Cash & equivalents | $57.4M | $68.6M | $89.4M | $88.7M | $116.4M |
| Inventory | $141.0M | $138.3M | $145.2M | $142.3M | $125.9M |
| Total assets | $470.2M | $468.6M | $479.2M | $472.8M | $480.1M |
| Total liabilities | $389.1M | $423.5M | $425.6M | $419.7M | $411.3M |
| Shareholders' equity | $81.2M | $45.1M | $53.7M | $53.2M | $68.8M |
Source: SEC EDGAR filings · CIK 0001138723 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.